Literature DB >> 21121899

Involvement of the PLCε/PKCα pathway in human BIU-87 bladder cancer cell proliferation.

Yan Ling1, Luo Chunli, Wu Xiaohou, Zhang Qiaoling.   

Abstract

PLCε (phospholipase Cε), one of effectors belonging to the small GTPase superfamily, has been suggested to play a crucial role in carcinogenesis. However, its bio-function in bladder cancer has never been demonstrated. In our previous study, we found that PLCε mRNA was highly expressed in bladder cancer tissues. In the present study, we silenced the PLCε gene by shRNA (small-hairpin RNA) in the bladder cancer cell line BIU-87. The results showed that it significantly inhibited cell proliferation and arrested the cell cycle at G0/G1-phase. The regulation of cell characteristics has been related to PKCα (protein kinase Cα) activity. Further study showed that knockdown of the PLCε gene down-regulated oncogenes c-fos and c-jun. These results indicate that PLCε plays a crucial role in bladder cancer, and PLCε may be a key molecule regulating the signal pathway of bladder cancer proliferation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21121899     DOI: 10.1042/CBI20090101

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  12 in total

1.  Knockdown of PLCε inhibits inflammatory cytokine release via STAT3 phosphorylation in human bladder cancer cells.

Authors:  Xue Yang; Liping Ou; Min Tang; Yin Wang; Xiaorong Wang; E Chen; Jianjun Diao; Xiaohou Wu; Chunli Luo
Journal:  Tumour Biol       Date:  2015-07-09

Review 2.  PLCε signaling in cancer.

Authors:  Rui-Yan Zhang; Wen-Qi Du; Ying-Chun Zhang; Jun-Nian Zheng; Dong-Sheng Pei
Journal:  J Cancer Res Clin Oncol       Date:  2015-06-25       Impact factor: 4.553

3.  Nuclear factor-κB signaling pathway is involved in phospholipase Cε-regulated proliferation in human renal cell carcinoma cells.

Authors:  Hong-Fei Du; Li-Ping Ou; Xue-Dong Song; Yan-Ru Fan; Xue Yang; Bing Tan; Zhen Quan; Chun-Li Luo; Xiao-Hou Wu
Journal:  Mol Cell Biochem       Date:  2014-02-08       Impact factor: 3.396

4.  Phospholipase C ε-1 gene polymorphisms and prognosis of esophageal cancer patients from a high-incidence region in northern China.

Authors:  Rong-Miao Zhou; Yan Li; Na Wang; Xi Huang; Shi-Ru Cao
Journal:  Mol Clin Oncol       Date:  2017-10-27

5.  Elevated expression patterns and tight correlation of the PLCE1 and NF-κB signaling in Kazakh patients with esophageal carcinoma.

Authors:  Xiao-Bin Cui; Xue-Lian Pang; Su Li; Jing Jin; Jian-Ming Hu; Lan Yang; Chun-Xia Liu; Li Li; Shu Jun Wen; Wei-Hua Liang; Yun-Zhao Chen; Feng Li
Journal:  Med Oncol       Date:  2013-12-05       Impact factor: 3.064

6.  Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma.

Authors:  Xiao-Bin Cui; Su Li; Ting-Ting Li; Hao Peng; Ting-Ting Jin; Shu-Mao Zhang; Chun-Xia Liu; Lan Yang; Yao-Yuan Shen; Shu-Gang Li; Na Li; Yong Li; Jian-Ming Hu; Jin-Fang Jiang; Jing Suo; Yan Qi; Wei-Hua Liang; Liang-Hai Wang; Hong-Wei Dang; Li Li; Wei-Wei Cao; Yutao Wei; Chuan-Yue Wu; Xiang-Lin Yuan; Hong Zhou; Yu Zheng; Yun-Zhao Chen; Feng Li
Journal:  Oncotarget       Date:  2016-01-12

7.  Knockout of phospholipase Cε attenuates N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumorigenesis.

Authors:  Taimao Jiang; Tao Liu; Lin Li; Zhijun Yang; Yunfeng Bai; Dongye Liu; Chuize Kong
Journal:  Mol Med Rep       Date:  2016-01-12       Impact factor: 2.952

Review 8.  The controversial role of phospholipase C epsilon (PLCε) in cancer development and progression.

Authors:  Anna Tyutyunnykova; Gennady Telegeev; Anna Dubrovska
Journal:  J Cancer       Date:  2017-02-25       Impact factor: 4.207

9.  Lidocaine enhances the effects of chemotherapeutic drugs against bladder cancer.

Authors:  Xihua Yang; Lili Zhao; Meiping Li; Lei Yan; Shengwan Zhang; Zhenguo Mi; Liansheng Ren; Jun Xu
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

10.  MicroRNA-34a functions as a tumor suppressor by directly targeting oncogenic PLCE1 in Kazakh esophageal squamous cell carcinoma.

Authors:  Xiao-Bin Cui; Hao Peng; Ran-Ran Li; Jian-Qin Mu; Lan Yang; Na Li; Chun-Xia Liu; Jian-Ming Hu; Shu-Gang Li; Yutao Wei; Hong Zhou; Feng Li; Yun-Zhao Chen
Journal:  Oncotarget       Date:  2017-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.